Clinical trial Recruiting at 1 site Observational Ages Any age to 18

Evaluating blood markers in children with lupus

Official title: Assessment of Hematologic Indices in Juvenile Lupus Erythematosus Patients : Correlation With Disease Activity and Chronic Organ Damage in These Patients

Run by Sohag University · NCT06718283 · Data updated 2026-11-12

This study looks at blood markers in children with lupus to see how they relate to the severity of the disease and any long-term damage it may cause.

Quick facts

Study typeObservational
AgesAny age to 18 Years
SexAll
Enrollment50 (estimated)
SponsorSohag University
Academic / other
Locations1 site (Sohag)
StatusRecruiting
StartedNovember 30, 2024
Main results expectedOctober 15, 2025
Study endsFebruary 2, 2026
Registry record updatedDecember 5, 2024
Trial IDNCT06718283 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children diagnosed with juvenile systemic lupus erythematosus who meet specific diagnostic criteria.

Probably not a fit

Patients with adult-onset lupus or other chronic inflammatory disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the relationship between various hematologic indices in children diagnosed with juvenile systemic lupus erythematosus (SLE) and their correlation with disease activity and chronic organ damage. Researchers will calculate important indices such as the systemic inflammatory index and correlate these with established disease activity and damage indices. The observational nature of the study allows for a comprehensive analysis of these relationships without any interventions.

Why it matters

Potential benefit: If successful, this study could provide valuable biomarkers for monitoring disease activity and organ damage in juvenile lupus patients.

How similar studies have gone: While there have been studies on hematologic indices in lupus, this specific correlation in juvenile patients is less explored, making this approach somewhat novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients who fillful 2012 SLICC criteria or 2019 ACR/EULAR criteria of systemic lupus erythematosus
* Age of patients at disease onset before 18 years

Exclusion Criteria:

* Adult onset disease ( age at disease onset after 18 years
* Any other chronic inflamatory disorders or other autoimmune diseases

Where it's running

  • Faculty of medicine
    Sohag, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.